Kelun, Merck's lung cancer combo improves survival in late-stage China trial - Reuters

Reuters | May 21, 2026, 6:04 p.m. | Original
Kelun, Merck's lung cancer combo improves survival in late-stage China trial Reuters
Trump postpones AI executive order, cites need to compete with China - Reuters Workday beats first-quarter estimates on steady software demand - Reuters